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Abstract 
Research suggests that the prevalence and incidence of cognitive impairment among older adults 
is decreasing. This analysis used data from 9 waves (1993–2016) of the Hispanic Established 
Populations for the Epidemiologic Study of the Elderly to assess cognitive status and cognitive 
decline for 2 cohorts of Mexican-Americans aged ≥75 years in 1993–1994 versus 2004–2005. 
Logistic regression, joint longitudinal survival models, and illness-death models for interval-
censored data were used to examine cohort differences in the odds of prevalent cognitive 
impairment, trajectories of cognitive decline, and the risk of 10-year incident cognitive 
impairment, respectively. Results indicated that compared with the 1993–1994 cohort, the 2004–
2005 cohort had higher odds for prevalent cognitive impairment (odds ratio = 2.51, 95% 
confidence interval (CI): 1.92, 3.29), particularly among participants with <4 years of education 
(odds ratio = 2.99, 95% CI: 2.14, 4.18). Conversely, the 2004–2005 cohort exhibited 
significantly slower rates of cognitive decline (βˆ = 0.50, 95% CI: 0.39, 0.62) and had a 
significantly lower risk of incident cognitive impairment (hazard ratio = 0.75, 95% CI: 0.62, 
0.91) compared with the 1993–1994 cohort. This analysis provides mixed results for cohort 
trends in the cognitive health of older Mexican-Americans. Continued research is needed to 
identify risk factors that contribute to these population-level trends. 
Keywords: cognitive impairment, incidence, Mexican-Americans, prevalence 
Cognitive impairment and Alzheimer disease and related dementias (ADRD) are major public 
health concerns. Population aging will cause an increase in the number of older adults living with 
ADRD (1). However, several studies have observed decreasing trends in ADRD prevalence and 
incidence (2–12). These findings have been attributed to improved treatment of chronic diseases 
and higher educational attainment among older adults (13, 14). While not all studies have 
reported favorable trends in ADRD (15–17), cognitive impairment (18), or cognitive function 
(19, 20), these results suggest that promoting education, improving management of chronic 
diseases, and reducing vascular risk factors might be effective strategies for preventing ADRD 
(10). 
Racial and ethnic disparities in cognitive impairment and ADRD are well documented (21–25), 
although only a few trend studies have focused on minority populations (26–29). Investigators 
using data from the Health and Retirement Study reported that the prevalence of cognitive 
impairment from 1993 to 2004 among adults aged ≥70 years decreased 3.9% per year for non-
Hispanic white, 5.2% for black, and 4.7% for Hispanic persons (29). Findings from the 
Washington Heights–Inwood Columbia Aging Project revealed the risk of dementia among 
adults aged ≥65 years in 1999 compared with 1992 was 40% lower for non-Hispanic white, 48% 
lower for black, and 36% lower for Hispanic persons (28). Similarly, the age-specific incidence 
rate for dementia in 2 cohorts of African Americans aged ≥70 years from Indianapolis decreased 
from 3.6% in 1992 to 1.4% in 2001 (26). Conversely, an increase in the prevalence of cognitive 
impairment among Mexican-Americans aged ≥75 years has been reported (27). 
Hispanic Americans are the largest minority population in the United States (30). Hispanics have 
longer life expectancy than black and non-Hispanic white Americans (31) despite substantial 
disadvantages in socioeconomic and health characteristics (32, 33). This make older Hispanics a 
high-risk population for cognitive impairment and ADRD. This analysis uses data from the 
Hispanic Established Populations for the Epidemiologic Study of the Elderly (H-EPESE) to 
examine differences in the prevalence and incidence of cognitive impairment, and trajectories of 
cognitive decline between Mexican-Americans aged ≥75 years in 2004–2005 and 1993–1994. 
We hypothesized that: 1) Older Mexican-Americans in 2004–2005 would have higher odds of 
being cognitively impaired; 2) the 2004–2005 cohort would exhibit slower cognitive decline; and 
3) the risk of incident cognitive impairment would be lower for the 2004–2005 cohort. 
 
METHODS 
Sample 
The H-EPESE is a longitudinal study of Mexican-Americans aged ≥65 years, living in the 
Southwestern United States (Texas, California, Arizona, Colorado, and New Mexico) (34). The 
first observation wave was completed in 1993–1994, and 9 observation waves have been 
completed as of 2016. Details on the sampling procedures have been previously described (35, 
36). A multistage area-probability cluster sample was used to select census tracts in counties in 
which the Mexican-American population comprised at least 6.6% of the county population. 
Census blocks were then randomly selected to identify Mexican-Americans aged ≥65 years from 
a minimum of 400 households in each census tract. The baseline observation wave in 1993–1994 
had a response rate of 83% and was representative of 500,000 Mexican-Americans aged ≥65 
years living in the Southwestern United States (35). A new independent sample of 902 
participants aged ≥75 years was enrolled at wave 5 (2004–2005). This new cohort was added so 
that the H-EPESE reflected the increasing educational attainment and income among older 
Mexican-Americans (37). New participants were selected using sampling procedures consistent 
with those used in 1993–1994. Weights were calculated so that the new sample was 
representative of Mexican-Americans aged ≥75 years living in the Southwestern United States 
(37). 
The selection of the analytical sample for each cohort is presented in Figure Figure1.1. 
Participants who required a proxy to complete the baseline interview or were missing data for 1 
or more covariates at the baseline interview were excluded. Participants who required a proxy to 
complete the baseline interview were excluded because the H-EPESE does not include a proxy 
measure for cognition, and not all of the covariates included in this analysis are assessed by 
proxy interview. The analytical sample for analyses on prevalent cognitive impairment and 
trajectories of cognitive decline included 1,706 participants, 922 from the 1993–1994 cohort and 
784 from the 2004–2005 cohort. The analytical sample for incident cognitive impairment 
included 1,357 participants, 799 from the 1993–1994 cohort and 558 from the 2004–2005 cohort. 
 
 
Figure 1. 
Selection of the final analytical sample from the Hispanic Established Populations for the 
Epidemiologic Study of the Elderly, United States. A) 1993–1994 cohort; B) 2004–2005 cohort. 
Waves 1–5 were used for the 1993–1994 cohort and waves 5–9 were used for the 2004–2005 
cohort. The 2004–2005 cohort included only participants who entered into the H-EPESE at wave 
5. A total of 882 participants who were <75 years of age at wave 1 were also interviewed at wave 
5. We excluded these 882 participants from the 2004–2005 cohort so that the maximum number 
of times in which participants could be observed was identical for the 1993–1994 cohort and 
2004–2005 cohort. The 882 surviving participants were 1.4 years younger than participants 
included in the 2004–2005 cohort (P < 0.01), but there were no statistically significant 
differences in sex, education, or self-reported health conditions. 
Measures 
Outcomes of interest  
Cognitive functioning of participants who did not require a proxy to complete the interview was 
assessed using the Mini-Mental State Examination (MMSE) (38). Prior research has noted floor 
and ceiling effects that limit the MMSE in accurately measuring the cognitive functioning of 
older adults with very high or very low cognition (39, 40). Philipps et al. (41) have developed a 
methodology using latent process models (42, 43) to obtain transformed MMSE scores that 
minimize potential biases from floor/ceiling effects and account for the nonlinear relationship 
between a respondent’s initial MMSE score and the rate of change over time (41). The range of 
possible scores on the MMSE is 0–30, and the transformed scores are rescaled to a range of 0–
100 points (41). The normalized transformation of the raw MMSE scores can be obtained using 
the R (R Foundation for Statistical Computing, Vienna, Austria) package NormPsy (44). Results 
for cohort differences in the trajectories of cognitive decline according to the raw and normalized 
MMSE scores are presented. 
Cognitive impairment for participants who did not require a proxy to complete the interview was 
defined as scoring ≤18 points on the MMSE, to account for the low education and advanced age 
of the sample population. Incident cases of cognitive impairment were ascertained by identifying 
the first observation wave in which a participant scored ≤18 points on the MMSE. 
For the 1993–1994 cohort, the percentages of participants who required a proxy interview for 
waves 1–5 were 8.8%, 8.7%, 12.7%, 11.2%, and 14.1%, respectively. For the 2004–2005 cohort, 
the percentages of proxy interviews for waves 5–9 were 4.8%, 9.8%, 1.9%, 5.8%, and 11.7%, 
respectively. The H-EPESE survey specifies whether a proxy interview was required because of 
impaired cognition. Proxy respondents are also asked if the target participant has been diagnosed 
by a physician with Alzheimer disease. 
Covariates  
Selected covariates included age, sex, education, being born in the United States or Mexico (i.e., 
nativity), diabetes, heart disease, hypertension, stroke, and depression. All covariates were 
selected from the respective baseline observation waves. Diabetes, heart disease, hypertension, 
and stroke were based on self-report. Participants who reported never having been diagnosed 
with hypertension but who had a systolic blood pressure of ≥140 mm Hg or diastolic blood 
pressure of ≥90 mm Hg were also classified as having hypertension. Depression was defined as 
scoring ≥16 points on the Center for Epidemiologic Studies–Depression Scale (45). 
Analysis 
Independent sample t tests and χ2 tests were used to assess differences in baseline characteristics 
between the 1993–1994 cohort and 2004–2005 cohort. Logistic regression models were used to 
assess the odds of prevalent cognitive impairment among older Mexican-Americans in 2004–
2005 compared with 1993–1994. Logistic regression models were also used to estimate the 
predicted probability of prevalent cognitive impairment in the 1993–1994 cohort and 2004–2005 
cohort. The risk difference based on each logistic regression model was calculated by subtracting 
the predicted probability of cognitive impairment for the 2004–2005 cohort from the predicted 
probability of cognitive impairment for the 1993–1994 cohort. 
The trajectories of cognitive decline were assessed using joint longitudinal survival models (46). 
This approach was used because rates of cognitive decline increase prior to death (47, 48). A 
joint longitudinal survival model uses submodels to simultaneously estimate the trajectories of 
cognitive decline and risk of mortality. The cognitive trajectories were modeled using linear 
mixed-effects regression (49). This approach produces valid estimates when data is unbalanced 
because of differences in the number or timing of the observations of the participants (49, 50). 
Random effects for time (years since baseline) and intercept were included to allow for the 
trajectory and baseline estimates for cognitive functioning to vary for each participant. A term 
for the interaction of cohort × time was included to determine whether cognitive trajectories 
differed between the 1993–1994 cohort and 2004–2005 cohort. The cohort × time term 
significantly improved the fit of the linear mixed-effects regression models according to the 
Akaike information criterion. These models also included a dummy variable to indicate the first 
observation wave (e.g., 0, 1, 1, 1, 1) to account for potential practice effects on the MMSE (51). 
The survival model was estimated using Cox proportional hazards regression. The joint models 
were estimated using the R (R Foundation for Statistical Computing) package JM (52). 
The risk of incident cognitive impairment was examined using an illness-death model for 
interval-censored data (53, 54). This approach allows for participants who remained cognitively 
intact to develop cognitive impairment between their last observation and death. The model 
estimates 3 transitions: 1) cognitively intact to deceased; 2) cognitively intact to cognitively 
impaired; and 3) cognitively impaired to deceased. These estimates are based on the age at which 
a participant is last observed to be cognitively intact, the age at which a participant is first 
observed to be cognitively impaired, and age at death. The illness-death models were estimated 
using the R (R Foundation for Statistical Computing) package SmoothHazard (55). 
Covariates were added into the analyses using a series of models. Model 1 controlled for age 
(centered at the sample mean), sex (referent: male), and nativity (referent: foreign-born). A 
model for the risk of incident cognitive impairment that controlled for baseline MMSE score is 
also presented. Model 2 added years of education. Years of education was dichotomized as ≥4 
and <4 years for regression models that included a term for interaction of education × cohort. 
Model 3 added diabetes, heart disease, hypertension, stroke, and depression. A fourth model for 
the trajectories of cognitive decline included terms for interaction between time and each 
covariate. Subsequent analyses were conducted to test for interactions between cohort and each 
covariate to determine whether cohort differences in the odds of prevalent cognitive impairment, 
trajectories of cognitive decline, and risk of incident cognitive impairment varied according to 
specific sociodemographic and health characteristics. The H-EPESE sampling weights were used 
to account for the survey design. All analyses were completed using R (R Foundation for 
Statistical Computing), version 3.1.0 (56). 
RESULTS 
The descriptive characteristics of the final sample are presented in Table Table1.1. Participants 
in the 2004–2005 cohort were older, were more likely to be born in the United States, completed 
more years of education, and were more likely to have diabetes or hypertension, to be 
cognitively impaired, and to have lower mean scores on the raw and transformed MMSE. The 
1993–1994 cohort was more likely to have experienced a stroke and depression. Among all US-
born participants, the 2004–2005 cohort completed an average of 6.3 years of education 
compared with 5.1 years for the 1993–1994 cohort (P < 0.01). The mean years of education 
among all foreign-born participants was 3.5 for the 2004–2005 cohort and 3.6 for the 1993–1994 
cohort (P = 0.59).  
Table 1. Baseline Characteristics of 2 Cohorts, Hispanic Established Populations for the 
Epidemiologic Study of the Elderlya, United States, 1993–1994 and 2004–2005 
Characteristic 
1993–1994 Cohort (n = 922) 2004–2005 Cohort (n = 784) 
P Value 
No. of Persons % No. of Persons % 
Age, yearsb 80.5 (0.22) 81.2 (0.22) 0.02 
Female sex 544 58.6 461 59.7 0.61 
US born 455 44.8 436 55.9 <0.01 
Years of educationb 4.3 (0.16) 5.0 (0.22) <0.01 
Diabetes 281 22.6 277 36.2 <0.01 
Heart disease 124 14.5 88 13.4 0.54 
Hypertension 575 65.5 549 72.1 <0.01 
Stroke 78 10.6 62 7.4 0.02 
Depression 228 26.2 143 21.5 0.02 
Cognitively impaired 123 15.3 226 27.9 <0.01 
Raw MMSE scoreb 23.1 (0.35) 21.1 (0.26) <0.01 
Transformed MMSE scoreb 55.5 (1.12) 47.6 (0.93) <0.01 
Abbreviation: MMSE, Mini-Mental State Examination. 
a Percentages and standard errors were calculated using the sample weights from the Hispanic Established Populations for the 
Epidemiologic Study of the Elderly. 
b Values are expressed as mean (standard error). 
  
Prevalent cognitive impairment 
The 2004–2005 cohort had 2.11 (95% confidence interval (CI): 1.65, 2.71) times higher odds of 
being cognitively impaired at baseline compared with the 1993–1994 cohort independent of age, 
sex, and nativity (Table (Table2).2). The odds of cognitive impairment increased to 2.37 (95% 
CI: 1.82, 3.11) after controlling for education and to 2.51 (95% CI: 1.92, 3.29) after controlling 
for health characteristics. The risk differences between the 2004–2005 cohort and 1993–1994 
cohort for models 1–3 were 11.95 (95% CI: 8.12, 15.78), 13.29 (95% CI: 9.51, 17.07), and 13.74 
(95% CI: 10.00, 17.47), respectively (Table (Table22).  
Table 2. Odds Ratios for Cognitive Impairment Among Mexican-Americans Aged ≥75 Years, 
Hispanic Established Populations for the Epidemiologic Study of the Elderlya, United States, 
2004–2005 Cohort Compared With 1993–1994 Cohort 
Variable 
Model 1 Model 2 Model 3 
OR 
95% 
CI 
Risk 
Difference 
95% 
CI 
OR 
95% 
CI 
Risk 
Difference 
95% 
CI 
OR 
95% 
CI 
Risk 
Difference 
95% CI 
2004–2005 cohort 
overall 
2.11 
1.65, 
2.71 
11.95 
8.12, 
15.78 
2.37 
1.82, 
3.11 
13.29 
9.51, 
17.07 
2.51 
1.92, 
3.29 
13.74 
10.00, 
17.47 
Age 1.10 
1.07, 
1.13 
  1.09 
1.07, 
1.12 
  1.10 
1.07, 
1.13 
  
Female sex 1.17 
0.91, 
1.51 
  1.20 
0.92, 
1.57 
  1.11 
0.85, 
1.46 
  
US born 0.83 
0.65, 
1.07 
  1.02 
0.78, 
1.34 
  0.99 
0.75, 
1.29 
  
Education     0.87 
0.84, 
0.90 
  0.87 
0.84, 
0.91 
  
Diabetes         1.28 
0.96, 
1.69 
  
Heart disease         0.82 
0.55, 
1.20 
  
Hypertension         0.70 
0.53, 
0.93 
  
Stroke         2.92 
1.93, 
4.39 
  
Depression         1.55 
1.15, 
2.08 
  
Abbreviations: CI, confidence interval; OR, odds ratio. 
a Results are from multivariable logistic regression models. Model 1 controlled for age, sex, and nativity. Model 2 controlled for 
covariates in model 1 plus education. Model 3 controlled for covariates in model 2 plus diabetes, heart disease, hypertension, 
stroke, and depression. 
The results from the interaction analyses revealed that the increased odds of prevalent cognitive impairment for the 2004–2005 
cohort varied according to educational attainment (P for interaction = 0.03). The 2004–2005 cohort had 1.85 (95% CI: 1.20, 2.88) 
times higher odds of cognitive impairment among participants with ≥4 years of education compared with 2.99 (95% CI: 2.14, 
4.18) higher odds among participants with low education. 
Trajectories of cognitive decline 
The 2004–2005 cohort showed significantly slower rates of cognitive decline compared with the 
1993–1994 cohort (Table (Table3;3; Figure Figure2A).2A). The rate of decline for the 2004–
2005 cohort was 0.53 points (95% CI: 0.43, 0.63) per year less compared with the 1993–1994 
cohort, controlling for age, sex, and nativity. This finding remained consistent after controlling 
for years of education (model 2), health characteristics (model 3), and interactions between time 
and the covariates (model 4). None of the 3-way interaction terms for cohort × time × covariates 
were statistically significant. The results for the normalized MMSE scores were consistent with 
the primary analysis (Table (Table4;4; Figure Figure22B).  
Table 3. Differences in Cognitive Decline for Mexican-Americans Aged ≥75 Years (Raw 
Scores), Hispanic Established Populations for the Epidemiologic Study of the Elderlya, United 
States, 2004–2005 Cohort Compared With 1993–1994 Cohort 
Variablea 
Raw MMSE Scoresb 
Model 1 Model 2 Model 3 Model 4 
βˆ 95% CI βˆ 95% CI βˆ 95% CI βˆ 95% CI 
2004–2005 cohort overall −1.53 −1.94, −1.22 −1.94 −2.33, −1.54 −2.07 −2.48, −1.67 −2.03 −2.41, 1.66 
Time −1.02 −1.10, −0.94 −1.00 −1.10, −0.90 −0.98 −1.08, −0.87 −0.87 −1.00, 0.75 
Cohort × time 0.53 0.43, 0.63 0.52 0.41, 0.62 0.50 0.39, 0.62 0.58 0.48, 0.67 
Age −0.33 −0.37, −0.29 −0.29 −0.33, −0.25 −0.29 −0.33, −0.25 −0.26 −0.30, −0.22 
Female sex −0.20 −0.57, 0.17 −0.17 −0.53, 0.18 −0.003 −0.37, 0.36 −0.05 −0.42, 0.32 
US born 0.84 0.47, 1.21 −0.14 −0.51, 0.22 −0.14 −0.51, 0.22 −0.20 −0.58, 0.18 
Education   0.49 0.41, 0.62 0.47 0.42, 0.52 0.47 0.42, 0.52 
Diabetes     −0.07 −0.47, 0.32 −0.20 −0.61, 0.22 
Heart disease     0.51 −0.06, 1.08 0.64 0.08, 1.20 
Hypertension     0.32 −0.06, 0.69 0.32 −0.07, 0.71 
Stroke     −2.10 −2.79, −1.41 −1.92 −2.62, −1.22 
Depression     −1.74 −2.19, −1.29 −1.62 −2.08, −1.16 
Covariate × time         
 Age       −0.08 −0.09, −0.07 
 Female sex       −0.04 −0.13, 0.05 
 US born       0.04 −0.06, 0.13 
 Education       −0.02 −0.03, −0.01 
 Diabetes       −0.11 −0.22, 0.001 
 Heart disease       −0.06 −0.21, 0.09 
 Hypertension       −0.07 −0.16, 0.03 
 Stroke       −0.03 −0.26, 0.19 
 Depression       −0.19 −0.31, 0.07 
Abbreviations: CI, confidence interval; MMSE, Mini-Mental State Examination. 
a The coefficient for the practice effect term is suppressed from the table. 
b Results are from joint longitudinal-survival models. Model 1 controlled for age, sex, and nativity. Model 2 controlled for 
covariates in model 1 plus education. Model 3 controlled for covariates in model 2 plus diabetes, heart disease, hypertension, 
stroke, and depression. Model 4 controlled for covariates in model 3 plus interaction terms between time and all covariates. 
 
 
Figure 2. 
Predicted trajectories of raw (A) and normalized (B) Mini-Mental State Examination (MMSE) 
scores for participants in the 2004–2005 and 1993–1994 cohorts of the Hispanic Established 
Populations for the Epidemiologic Study of the Elderly, United States. Predicted trajectories are 
for the reference category: men, age-centered, a dummy variable for practice effects, foreign 
born, and mean years of education. 
Table 4. Differences in Cognitive Decline Among Mexican-Americans Aged ≥75 Years 
(Normalized Scores), Hispanic Established Populations for the Epidemiologic Study of the 
Elderlya, United States, 2004–2005 Cohort Compared With 1993–1994 Cohort 
Variablea 
Normalized MMSE Scoresb 
Model 1 Model 2 Model 3 Model 4 
βˆ  95% CI βˆ  95% CI βˆ  95% CI βˆ  95% CI 
2004–2005 cohort overall −4.79 −6.59, −2.98 −6.42 −8.09, −4.74 −6.43 −8.12, −4.75 −6.83 −8.56, −5.10 
Time −2.39 −2.69, 2.09 −2.34 −2.64, −2.05 −2.35 −2.64, 2.05 −2.21 −2.67, −1.74 
Cohort × time 1.73 1.34, 2.11 1.77 1.39, 2.15 1.79 1.41, 2.17 1.92 1.56, 2.27 
Age −1.35 −1.52, −1.18 −1.07 −1.22, −0.91 −1.10 −1.25, −0.95 −0.95 −1.13, −0.76 
Female −0.53 −2.04, 0.99 −0.46 −1.84, 0.92 0.12 −1.27, 1.52 0.23 −1.50, 1.96 
US born 3.38 1.88, 4.88 −1.16 −2.57, 0.25 −1.24 −2.64, 0.16 −1.32 −3.07, 0.42 
Education   2.27 2.09, 2.45 2.21 2.03, 2.39 2.27 2.05, 2.50 
Diabetes     −1.78 −3.32, −0.23 −1.34 −3.24, 0.56 
Heart disease     1.99 −0.15, 4.13 2.47 −0.12, 5.07 
Hypertension     0.01 −1.42, 1.45 0.37 −1.43, 2.17 
Stroke     −3.58 −6.17, 1.01 −4.66 −7.79, −1.52 
Depression     −5.12 −6.84, 3.41 −4.96 −7.05, −2.87 
Covariate × time         
 Age       −0.15 −0.20, −0.11 
 Female       0.03 −0.32, 0, 38 
 US born       0.20 −0.16, 0.55 
 Education       −0.09 −0.13, 0.05 
 Diabetes       −0.29 −0.69, 0.11 
 Heart disease       −0.29 −0.83, 0.26 
 Hypertension       −0.09 −0.45, 0.27 
 Stroke       0.16 −0.53, 0.86 
 Depression       −0.18 −0.62, 0.26 
Abbreviations: CI, confidence interval; MMSE, Mini-Mental State Examination. 
a The coefficient for the practice effect term is suppressed from the table. 
b Results are from joint longitudinal-survival models. Model 1 controlled for age, sex, and nativity. Model 2 controlled for 
covariates in model 1 plus education. Model 3 controlled for covariates in model 2 plus diabetes, heart disease, hypertension, 
stroke, and depression. Model 4 controlled for covariates in model 3 plus interaction terms between time and all covariates. 
  
Incident cognitive impairment 
A total of 496 incident cases of cognitive impairment were identified. This included 317 cases in 
the 1993–1994 cohort and 179 cases in the 2004–2005 cohort. The overall 10-year incidence rate 
per 100 person-years was 6.32 (95% CI: 5.79, 6.90). The incidence rate was significantly lower 
for the 2004–2005 cohort (5.24, 95% CI: 4.51, 6.04) compared with the 1993–1994 cohort (7.18, 
95% CI: 6.41, 7.99). The average age for identification of cognitive impairment was 86.6 years 
for the 2004–2005 cohort and 86.2 years for the 1993–1994 cohort (P = 0.32). The average age 
of death for participants who became cognitively impaired was 89.8 years for the 2004–2005 
cohort and 89.6 years for the 1993–1994 cohort (P = 0.51). 
The 2004–2005 cohort had 0.78 (95% CI: 0.65, 0.94) times the risk of incident cognitive 
impairment as the 1993–1994 cohort (Table (Table5).5). After controlling for baseline MMSE 
score, the 2004–2005 cohort had 0.75 (95% CI: 0.62, 0.90) times lower risk of incident cognitive 
impairment compared with the 1993–1994 cohort. The lower risk of incident cognitive 
impairment for the 2004–2005 cohort was attenuated when controlling for years of education but 
remained statistically significant (hazard ratio = 0.77, 95% CI: 0.64, 0.93). Controlling for 
baseline health conditions did not substantially change the risk of incident cognitive impairment 
in the 2004–2005 cohort (hazard ratio = 0.75, 95% CI: 0.62, 0.91).  
Table 5. Hazard Ratios for 10-Year Incident Cognitive Impairment Among Mexican-
Americans Aged ≥75 Years, Hispanic Established Populations for the Epidemiologic Study of 
the Elderlya, United States, 2004–2005 Cohort Compared With 1993–1994 Cohort 
Variable 
Model 1 Model 2 Model 3 Model 4 
HR 95% CI HR 95% CI HR 95% CI HR 95% CI 
2004–2005 cohort overall 0.78 0.65, 0.94 0.75 0.62, 0.90 0.77 0.64, 0.93 0.75 0.62, 0.91 
Female sex 0.98 0.82, 1.18 1.02 0.85, 1.22 1.01 0.84, 1.22 0.99 0.82, 1.19 
US born 1.14 0.95, 1.37 1.22 1.01, 1.47 1.26 1.04, 1.51 1.25 1.04, 1.51 
Baseline MMSE   0.92 0.90, 0.95 0.93 0.90, 0.96 0.93 0.90, 0.96 
Education     0.98 0.95, 1.01 0.97 0.95, 1.00 
Diabetes       1.20 0.98, 1.46 
Heart disease       1.24 0.94, 1.63 
Hypertension       1.26 1.03, 1.53 
Stroke       1.37 0.99, 1.92 
Depression       1.09 0.88, 1.37 
Abbreviations: CI, confidence interval; HR, hazard ratio; MMSE, Mini-Mental State 
Examination. 
a Results are from illness-death models for interval-censored data. Model 1 controlled for sex and 
nativity. Model 2 controlled for covariates in model 1 plus baseline MMSE score. Model 3 
controlled for covariates in model 2 plus education. Model 4 controlled for covariates in Model 4 
plus diabetes, heart disease, hypertension, stroke, and depression. 
 
DISCUSSION 
The present analysis examined cohort differences in the odds of prevalent cognitive impairment, 
trajectories of cognitive decline, and risk of incident cognitive impairment among older 
Mexican-Americans. We observed that Mexican-Americans aged ≥75 years in 2004–2005 had 
approximately 2.5 times higher odds of being cognitively impaired compared with Mexican-
Americans aged ≥75 years in 1993–1994. The higher odds of prevalent cognitive impairment for 
the 2004–2005 cohort were greatest among participants who completed <4 years of education. 
Conversely, the 2004–2005 cohort exhibited significantly slower rates of cognitive decline and 
had a significantly lower risk of incident cognitive impairment over a 10-year period. 
The prevalence of a disease is based on disease incidence and duration. A potential explanation 
for the higher prevalence but lower incidence of cognitive impairment in the 2004–2005 cohort 
is that this cohort might be living longer with cognitive impairment. However, the illness-death 
model indicated that the risk of transitioning from cognitively impaired to deceased was not 
significantly different between the 2 cohorts. Prior studies have not investigated cohort 
differences in survival following the onset of cognitive impairment in the H-EPESE. In our 
sample, the average time between age of first being observed to be cognitively impaired and 
death was 3.20 years for the 2004–2005 cohort and 3.38 years for the 1993–1994 cohort. A 
recent analysis of data from the Framingham Heart Study revealed that survival after a diagnosis 
of dementia had decreased from an average of 6 years in 1977–1984 to 3 years in 2004–2008 
(57). A compression of morbidity for cognitive impairment has also be observed in the Health 
and Retirement Study (58). 
The decreasing trends for ADRD prevalence and incidence among recent cohorts of older adults 
have been attributed to increased educational attainment (13). We observed that the 2004–2005 
cohort had significantly higher odds of prevalent cognitive impairment compared with the 1993–
1994 cohort despite the 2004–2005 cohort’s having completed nearly 1 year of education more 
on average. The decreased risk of incident cognitive impairment remained statistically significant 
after controlling for education. A possible explanation for this finding is that increases in 
education have not coincided with improvements in educational quality. Past research indicates 
that reading ability and other measures that approximate educational quality are stronger 
predictors of cognitive functioning than educational attainment, especially for minority older 
adults (59, 60). Educational quality is also important to consider given that a significantly higher 
percentage of participants in the 2004–2005 cohort were born in the United States compared with 
the 1993–1994 cohort. The United States and Mexico have substantially different educational 
systems, which could influence an individual’s risk of cognitive impairment through disparities 
in educational quality. 
We observed that US-born participants had significantly higher risk of incident cognitive 
impairment compared with foreign-born participants. However, a term for interaction between 
cohort and nativity was not statistically significant. Prior research indicates that nativity 
differences in cognitive functioning are influenced by sex and, for foreign-born Mexican-
Americans, the age at which an individual migrated to the United States. Foreign-born Mexican-
American men who migrated to the United States as middle-aged adults show slower rates of 
cognitive decline (61) and have a lower risk of cognitive impairment (62) compared with US-
born Mexican-American men. However, foreign-born Hispanics regardless of sex have been 
observed to live longer with cognitive impairment than US-born Hispanics (31, 63). 
The 2004–2005 cohort also had significantly higher prevalence of diabetes and hypertension. 
Diabetes and midlife hypertension are important risk factors for ADRD (64). However, 
controlling for health conditions explained very little of the decreased risk of incident cognitive 
impairment in the 2004–2005 cohort. Prior studies have reported that health characteristics 
explained only a small amount of the decrease in ADRD incidence (2, 9), although reducing the 
prevalence of chronic health conditions and increased engagement in positive health behaviors 
might have a substantial impact on the prevalence of ADRD (64). 
This analysis has important limitations. First, the MMSE is the only measure of cognitive 
functioning in the H-EPESE. The MMSE was originally designed to be used in clinical settings 
as a screening tool for ADRD and severe cognitive impairment (39). The MMSE has limited 
accuracy for detecting ADRD in community settings (65), especially among older adults with 
low educational attainment (65) or whose first language is not English (66). Consequently, some 
H-EPESE participants might have been incorrectly classified as cognitively impaired or 
cognitively intact. We also did not consider functional limitations, which must be present to 
warrant a clinical diagnosis ADRD (67), in our definition of cognitive impairment. Comparing 
trends reported in different studies is complicated by the fact that diagnostic criteria for ADRD 
vary across studies, and this can dramatically decrease or increase estimates (68, 69). Our 
estimates for the prevalence and incidence of cognitive impairment would have been lower had 
participants been required to be functionally impaired as well. 
A second limitation is that the MMSE has poor psychometric properties for detecting changes in 
cognitive functioning (39, 70). We analyzed trajectories of cognitive decline using the raw 
MMSE scores and using a normalized transformation of the MMSE to account for floor/ceiling 
effects. While these analyses produced consistent results, our findings need to be replicated using 
data for older Mexican-Americans that include a comprehensive cognitive evaluation. The 
findings for the trajectories of cognitive decline might have also been influenced by the lower 
percentage of proxy interviews in the 2004–2005 cohort compared with the 1993–1994 cohort. 
An additional limitation is that the H-EPESE does not include information for potentially 
important risk factors such as level of physical activity or midlife health conditions. We also did 
not control for other measures of socioeconomic status, such as income. However, it is unlikely 
that controlling for income would have substantially changed our results given that 
approximately 75% of participants in both cohorts reported having a yearly household income of 
less than $15,000. Finally, it is important to consider the representativeness of the sample 
populations with respect to the general population of Mexican-Americans aged ≥75 years living 
in the Southwestern United States. The H-EPESE sampling procedures were designed so that 
participants in both cohorts were representative of older Mexican-Americans living in the 
Southwestern United States during the 1990s and 2000s. The 2004–2005 cohort had higher 
educational attainment than the 1993–1994 cohort, and educational attainment has continued to 
increase among older Hispanics since 2005 (33). The prevalence of chronic health conditions 
associated with greater risk of cognitive impairment has also increased among Hispanics (71). 
Population-level changes of risk factors for cognitive impairment make it important to continue 
monitoring trends in ADRD and cognitive impairment prevalence and incidence among older 
Mexican-Americans. 
To summarize, this analysis detected significant cohort differences in the odds of prevalent 
cognitive impairment, risk of incident cognitive impairment, and rates of cognitive decline 
among Mexican-Americans aged ≥75 years. Future research is needed to identify potentially 
modifiable environmental, social, neighborhood, health, and lifestyle characteristics that 
contribute to cohort differences in cognitive impairment and cognitive decline among older 
Mexican-Americans. 
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